Organisation paid for research Program year 2025 Source: CMS Open Payments

Accellacare McFarland

Neither a doctor nor a teaching hospital

Research payments

$115,689

6 payments

Through program year 2025, Accellacare McFarland is reported as receiving $115,689 in research payments, across 6 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $265 3
2022 Research $5,800 1
2021 Research $109,624 2

Breakdown

Who paid Research payments · program years 2021–2025
  1. OraSure Technologies Inc. $115,424 3 payments
  2. Pfizer Inc. $265 3 payments
Studies the money was for Research payments · program years 2021–2025
  1. InteliSwab COVID-19 Rapid Test Clinical Evaluation Study in Asymptomatic Individuals $115,424 3 payments
  2. A Phase 3 Study to Investigate the Safety Tolerability and Immunogenicity of Revaccinating Pregnant Participants During Subsequent Pregnancies and Persistence of Immunity of A Single Dose of A Bivalent Respiratory Syncytial Virus RSV Vaccine $265 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record